The Mumdipharma restructure appears to be a net benefit to MVP. Only 8 million EU to buyback European rights with all of the market development work done to date.
The Mumdipharma restructure appears to be a net benefit to MVP....
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.005(1.05%) |
Mkt cap ! $40.99M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 51.5¢ | 47.0¢ | $14.98K | 31.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23436 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 198 | 2 |
View Market Depth
| Last trade - 14.54pm 12/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |